Gypenoside XLIX protects against acute kidney injury by suppressing IGFBP7/IGF1R-mediated programmed cell death and inflammation
Qin Yang, Hongmei Zang, Xing Tian, Shaofei Zhang, Chao Li, Yao Zhang, Yuhang Dong, Xiaowei Hu, Ju-tao Yu, Jiagen Wen, Juan Jin, Jun Li, Ren Zhao, Taotao Ma, Xiao‐Ming Meng
Topics & Concepts
ChemistryAcute kidney injuryNecroptosisPharmacologyKidneyCisplatinProgrammed cell deathInflammationInternal medicineBiochemistryApoptosisMedicineChemotherapyNatural Compounds in Disease TreatmentGinseng Biological Effects and ApplicationsChemotherapy-induced organ toxicity mitigation